| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Compass Therapeutics, Inc.'s insiders have accumulated 22,500 shares worth roughly $21K on balance. In the past 30 days, 1 insider bought and 0 sold. Recent activity has leaned to the buy side.
The largest recent buyer is Lerner Neil (Chief Accounting Officer), now holding an estimated $386K in CMPX. A senior officer buying with their own money is generally read as a stronger signal than routine insider selling.
CMPX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 6.60M | $43.05M | - | |
| Other | 1.00M | - | - | |
| Other | 1.00M | - | - | |
| CFO | 670.0K | - | - | |
| Other | 420.0K | $386.4K | +22.5K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2020 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 97,431 | $5.00 | $487,155.00 | +2.2% | |
| Jun 19, 2020 | Gordon Carl L74 | Director, 10% Owner | Buy | 1,455,132 | $5.00 | $7,275,660.00 | +12.9% | |
| Jun 19, 2020 | Sunderland Julie | Director | Buy | 289,118 | $5.00 | $1,445,590.00 | +13.1% |